
Sign up to save your podcasts
Or


In this episode of the IJGC podcast, Dr. Pedro Ramirez interviews Dr. Michael Frumovitz about his recent publication in Lancet Oncology on the quality of life endpoints from the LACC trial. Tune in! You might be very surprised with their results!
By BMJ Group5
2323 ratings
In this episode of the IJGC podcast, Dr. Pedro Ramirez interviews Dr. Michael Frumovitz about his recent publication in Lancet Oncology on the quality of life endpoints from the LACC trial. Tune in! You might be very surprised with their results!

37 Listeners

52 Listeners

5 Listeners

8 Listeners

5 Listeners

3 Listeners

2 Listeners

3 Listeners

8 Listeners

38 Listeners

14 Listeners

1 Listeners

51 Listeners

0 Listeners

6 Listeners

14 Listeners

3 Listeners

3 Listeners

23 Listeners